Obermatt
See Similar Stocks →

Benitec Biopharma

NAQ:BNTC · US08205P2092
BiotechnologySmall

360° View

no current rank
Price/Sales43
Price/Earnings—
Price/Book55
Dividend Yield—
Revenue Growth—
Profit Growth57
Capital Growth40
TSR 52w10
Leverage97
Liquidity12
Refinancing75
Combined—
Analyst Opinions80
Pro Holdings47
Opinion Changes50
Market Pulse88

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees30
Websitebenitec.com
ISINUS08205P2092
Last UpdateApr 2, 2026
Index & Theme
Genetic DisorderGeneticsBiotechnologyHealth DiagnosticsMedicalTherapeutics

Description

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company engages in the discovery, development, and commercialization of therapeutic agents capable of addressing significant un…

Similar Stocks

The companies this stock is ranked against.

Compare Benitec Biopharma with its peers
Regenxbio
NSQ:RGNX
17
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Stoke Therapeutics
NSQ:STOK
16
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Beam Therapeutics
NSQ:BEAM
17
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Voyager Therapeutics
NSQ:VYGR
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Taysha Gene Therapies
NSQ:TSHA
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Pacific Biosciences of California
NSQ:PACB
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →